Top Articles

As you may have heard, the FTC recently reached a significant settlement with an adware firm by the name of Zango. So, what are

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

the lessons learned from the settlement?

The FTC and Zango Settlement Regarding Adware

According to FTC filings, Zango was a ra

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ther prolific adware firm. From 2002 to 2005, Zango distributed its adware product to the huge number of Internet users without

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

their knowledge according to the FTC. The product was placed on the computers of individuals when they went to download free gam

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

s, screensavers and such. On top of this, the FTC alleged that Zango and its affiliates placed the programs on computers in such

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

a way that it was difficult to both find and remove them.

The basis of the claim against Zango, which used to be known as 180sol

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

utions, was that it failed to give proper notice to consumers that they were downloading adware onto their computers when they se

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ected a free download. In turn, Zango took the position that they had done nothing wrong. Instead, it was those nasty affiliate

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

s that were doing all of the frivolous action. Surprise, surprise.

Based on the settlement which amounted to $3 million, it wou

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

ld appear that the FTC claims had more than a bit of merit. That being said, what legal lessons can we draw from the situation?

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ill adware now go away?

Many privacy advocates have hailed the settlement as a landmark case in the war against adware on the In

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

ternet. But is it really? While it's certainly sets a precedent regarding the fact that the FTC is looking at various adware fi

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

rms, it hardly strikes me as something that is going to make such companies tremble in their boots. Why? It is a fairly well-kn

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

own fact that the FTC is seriously under budgeted an undermanned. When it comes to controlling the Internet, most FTC cases are

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

esigned to be high profile so they can set examples that the agency hopes will deter others from taking such action.

At this poi

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

nt, I have serious doubts that the FTC will make much headway against adware firms with this settlement. Yes, adware firms are p

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

robably concerned at the moment about the potential for being the next party targeted by the FTC, but how long will that concern

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

eally last? Probably about as long as it takes to get the next set of revenues from their programs!

That being said, the FTC sh

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ould be applauded for taking action against one of the more obvious adware situations. Still, while a $3 million fine may sound

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

like a lot, one has to wonder how much money Zango made from 2002 and 2005. I'm willing to bet it was a bit more than $3 million

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.toparticles.org.ua/article/129519/toparticles-The-FTC-and-Zango-Settlement-Regarding-Adware.html">The FTC and Zango Settlement Regarding Adware</a>

BB link (for phorums):
[url=http://www.toparticles.org.ua/article/129519/toparticles-The-FTC-and-Zango-Settlement-Regarding-Adware.html]The FTC and Zango Settlement Regarding Adware[/url]

Every business relationship has something that annoys the other party. This article discusses ways to deal with these annoyances, whether it is to eliminate them or move on.

Banks provide their financial services to clients through personal online banking, making banking more convenient for individuals who may not have the time to go to banks. However, these services are not only offered to clients’ personal accounts but are also available to owners of small businesses and to corporations as well. In the same way that personal banking is made easier, everyday banking is made simple, cost effective, and fast so that business owners can devote more time in running their businesses.

While Legal Romantics would like to characterize the trial of a lawsuit as a “Search For Truth” that’s not a reality! Cases are decided on the evidence. When reviewing cases before them, judges invar...

Tags

Links

Top Articles - The FTC and Zango Settlement Regarding Adware

Related Articles: